ASP Isotopes Inc. Common Stock logo

ASPIASP Isotopes Inc. Common Stock

NASDAQ · Basic Materials · Chemicals

$3.94

+$0.16 (+4.10%)

ASP Isotopes Inc. Common Stock (ASPI) is a chemicals company listed on NASDAQ. It is led by Paul Elliot Mann C.F.A., based in 601 Pennsylvania Avenue NW, Washington, DC, United States, 20004, with about 136 employees. ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes. It operates in two segments, Nuclear Fuels and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs. The company offers the Aerodynamic Separation Process (ASP) technology, which separates gas species and isotopes in a volatile state; and the Quantum Enrichment (QE) technology, which selectively ionizes and separates isotopes. It also produces and commercializes Molybdenum-100, Molybdenum-98, and Ytterbium-176 for the nuclear medical industry; Silicon-28, which is used in semiconductors; and Carbon-14 for pharmaceuticals and agrochemicals. In addition, the company develops Zinc-67/68, Nickel-68, and Xenon 129/136 for the nuclear medical industry; Lithium-6, Lithium-7, Uranium-235, Chlorine-37, and Thorium Fluoride for the energy industry; and Germanium-70/72/74. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

Latest reported ASPI revenue for 2025-09-30 was $4.9M. Net income was -$12.9M. Revenue was up 308.0% from 2025-06-30 to 2025-09-30. ASPI currently screens at market cap $620.7M.

Use this ASPI page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ASPI quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ASPI SEC filings page. Lician reads the product cache first so this HTML stays unique to ASP Isotopes Inc. Common Stock even when a live quote feed is slow.

About ASP Isotopes Inc. Common Stock

ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes. It operates in two segments, Nuclear Fuels and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs. The company offers the Aerodynamic Separation Process (ASP) technology, which separates gas species and isotopes in a volatile state; and the Quantum Enrichment (QE) technology, which selectively ionizes and separates isotopes. It also produces and commercializes Molybdenum-100, Molybdenum-98, and Ytterbium-176 for the nuclear medical industry; Silicon-28, which is used in semiconductors; and Carbon-14 for pharmaceuticals and agrochemicals. In addition, the company develops Zinc-67/68, Nickel-68, and Xenon 129/136 for the nuclear medical industry; Lithium-6, Lithium-7, Uranium-235, Chlorine-37, and Thorium Fluoride for the energy industry; and Germanium-70/72/74. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

ASPI Key Statistics

Market Cap

$620.68M

Volume

244,202

Previous Close

$3.89

Day Range

$3.91$3.98

00

EPS

-$0.63

Revenue

$4.14M

Net Income

-$32.42M

Gross Profit

$0.00

Free Cash Flow

$0.00

Revenue Growth

+857.0%

Profit Margin

-782.4%

Employees

136

ASPI Financials

Annual income statement in USD. Latest reported periods first.

ASPI annual income statement across FY2024, FY2023, FY2022
LineFY2024FY2023FY2022
Revenue$4.14M$433.03K$0.00
Cost of Revenue$0.00$0.00$0.00
Gross Profit$0.00$0.00$0.00
Operating Income$0.00$0.00$0.00
Net Income-$32.42M-$16.29M-$4.95M
EPS (Diluted)-$0.63-$0.49$0.00

Total Assets

$94.35M

Total Debt

$0.00

Shareholders' Equity

$0.00

Cash & Equivalents

$61.90M

Operating Cash Flow

-$16.70M

Free Cash Flow

$0.00

ASP Isotopes Inc. Common Stock Company Information

President, CEO & Executive Chairman
Paul Elliot Mann C.F.A.
Headquarters
601 Pennsylvania Avenue NW, Washington, DC, United States, 20004
Phone
202 756 2245
IPO / Founded
2022-11-10
Industry
Chemicals
Data Updated:

Upcoming Events for ASPI